The India diabetes market is on the verge of unprecedented growth, with projections indicating a remarkable climb from USD 6.86 billion in 2024 to approximately USD 13.77 billion by 2035. This surge is spurred by an anticipated compound annual growth rate (CAGR) of 6.54%. As society grapples with rising diabetes prevalence, the market's expansion reflects both a growing demand for innovative...